Key result
Etomidate induction suppresses postsurgical cortisol levels by ~87% versus ketamine in pediatric Tetralogy of Fallot.
Why the study?
The effect of a single induction dose of etomidate versus ketamine on plasma cortisol levels in children with TOF undergoing intra-cardiac repair on CPB was unclear.
Does etomidate compared to ketamine reduce plasma cortisol levels in children with Tetralogy of Fallot undergoing intra-cardiac repair on cardiopulmonary bypass?
RCT (n=30)
Random allocation
No
Does etomidate compared to ketamine reduce plasma cortisol levels in children with Tetralogy of Fallot undergoing intra-cardiac repair on cardiopulmonary bypass?
Absolute Event Rate: 5.78% vs 44.02%
p-value: p=0.000
A single induction dose of etomidate significantly suppresses the increase in serum cortisol associated with cardiopulmonary bypass compared to ketamine in children undergoing Tetralogy of Fallot repair.
May guide induction choice to blunt cortisol surge in pediatric TOF repair; confirms etomidate's greater suppression versus ketamine in this RCT population.
Objective: To compare the effect of a single induction dose of etomidate or ketamine on plasma cortisol levels in children with Tetralogy of Fallot (TOF) undergoing intra-cardiac repair on cardiopulmonary bypass (CPB). Design: A prospective randomized trial. Setting: Cardiac center of a tertiary care hospital. Participants: Thirty children with TOF undergoing intra-cardiac repair on CPB. Interventions: After random allocation of the children into two groups, the children either received etomidate 0.2 mg/kg or ketamine 2 mg/kg intravenously for anesthetic induction along with fentanyl 2 mcg/kg and midazolam 100 mcg/kg. Endotracheal intubation was accomplished with rocuronium bromide in the dose of 1 mg/kg. Anesthesia was maintained with sevoflurane in air-oxygen, titrated to response and supplemental vecuronium bromide for muscle relaxation, fentanyl chloride for pain relief. Serum cortisol was measured on three occasions, at preinduction, at the end of surgery and at 24 hours postoperatively. Measurements and Main Results: Baseline plasma cortisol (Normal 5 - 25 mcg/dl) in the etomidate group (19.91 ± 3.51 mcg/dl) decreased significantly at the end of surgery (5.78 ± 2.0 mcg/dl) and rose to significantly higher than baseline values at 24 hours (27.31 ± 8.30 mcg/dl). The baseline cortisol levels in the ketamine group (20.91 ± 3.19 mcg/dl) increased significantly at the end of surgery (44.02 ± 5.49 mcg/dl) and remained significantly higher than baseline at 24hours (45.93 ± 3.05 mcg/dl). Plasma cortisol levels in the etomidate group at end of surgery, and at 24 hours post-operatively, were significantly lower than the ketamine group. Conclusions: This study shows that etomidate is a suitable and safe agent for suppression of the increase in serum cortisol associated with the use of CPB in children with TOF undergoing intra-cardiac repair.
No takes yet. Share an insight, caveat, or question.
Pandey et al. (2012) conducted an RCT in Tetralogy of Fallot (n=30). Etomidate vs. Ketamine 2 mg/kg intravenously was evaluated on Plasma cortisol levels at the end of surgery (mcg/dl) (p=0.000). Etomidate induction significantly suppressed the increase in plasma cortisol levels at the end of surgery (5.78 mcg/dl) compared to ketamine (44.02 mcg/dl) in children with Tetralogy of Fallot.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: